Podcasts about cancer pain

In this episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable welcomes Dr. Duncan Lascelles, a distinguished professor at North Carolina State University and a leading expert in veterinary pain management and surgery. Dr. Lascelles explores the complex relationship between pain and cancer in veterinary patients, highlighting how both cancer and its treatments can cause significant discomfort—and how pain itself may even influence cancer progression. Together, they dive into findings from clinical and laboratory studies and share best practices for pain assessment and management. Dr. Lascelles also emphasizes the importance of early intervention, client education, and the profound impact of effective pain control on patient outcomes and quality of life. Tune in to gain a deeper understanding of how thoughtful pain management can shape the future of veterinary oncology.

When it comes to end-of-life care for patients with cancer, “I think that there is a real deficit in our training,” says Nathan I. Cherny, MD, director of the Cancer Pain and Palliative Medicine Service at Shaare Zedek Medical Center in Jerusalem, Israel. Dr. Cherney and colleagues recently examined factors contributing to oncologists overtreating patients at the end of life. He discusses key findings and ways to address this continued problem with Robert A. Figlin, MD, the Steven Spielberg Family Chair in Hematology-Oncology at the Cedars-Sinai Cancer Center in Los Angeles. “When one reads practice guidelines, they never include a section of when further treatment is more likely to be harmful than helpful,” Dr. Cherny notes. “Unless it appears in every illness guideline, the message does not necessarily get through that this is something that is really important.” Dr. Cherny reported serving as a consultant for and owning stock in Canopy Care. Dr. Figlin reported various financial relationships.

Wellness Rising from the Wellness House of Annapolis welcomes Craniosacral Therapist Lisa Manning, who talks about the approach and techniques she uses to help people deal with the pain and stress of cancer.

Episode Title: Ketamine for Cancer and Pain Management - Journal Club Host: David Rosenblum, MD Upcoming Free Webinars: 1. Exploring Innovative Mental Health Treatments which are well reimbursed    Discussing Spravato, Transmagnetic Stimulation, and Ketamine Infusion, sponsored by Big Leap Health. Register! 2. Understanding Scrambler Therapy    Learn about this revolutionary approach to pain management. Register! 3. Cervical Ultrasound: Anatomy and Interventional Pain Targets    Sponsored by Clarius, this session will explore advanced imaging techniques. Register! Sign up for the webinars and check out our full calendar of events. Join us for this insightful episode as we explore the potential of ketamine in transforming pain management practices! Summary In today's episode, we delve into the emerging role of ketamine in managing cancer and chronic pain. Our discussion is anchored around a comprehensive review article titled "Ketamine Use for Cancer and Chronic Pain Management," published in Frontiers in Pharmacology on February 1, 2021. This review, authored by Clayton Culp, Hee Kee Kim, and Salahadin Abdi, explores ketamine's potential as an analgesic in chronic pain conditions, particularly cancer-related neuropathic pain. Key Points from the Review Article: - Mechanism of Action: Ketamine functions as an N-methyl-D-aspartate receptor antagonist, providing analgesic effects at sub-anesthetic doses. Its ability to counteract central nervous system sensitization makes it effective in opioid-induced hyperalgesia. - Clinical Efficacy: Recent studies highlight ketamine's potential to reduce pain scores and opioid consumption, offering a promising alternative for patients with refractory pain. - Safety Profile: At lower doses used for analgesia, ketamine's safety and adverse event profile are significantly improved compared to its use as an anesthetic. - Pharmacogenomics and Interactions: The article discusses how genetic variations can affect ketamine metabolism and highlights potential drug interactions that clinicians should be aware of. Reference Culp, Clayton, Hee Kee Kim, and Salahadin Abdi. "Ketamine use for cancer and chronic pain management." Frontiers in Pharmacology 11 (2021): 599721.

Shivani Ruparel, Ph.D., Associate Professor and Director of Research in the Department of Endodontics at UT Health San Antonio, and her team are working on potential analgesics to help mitigate cancer pain.

Your patient is in terrible pain from cancer and you have the tools to relieve it. Yet they won't take the oxycontin or morphine that you prescribed. You can see that they are suffering yet you feel powerless to help. This is a common scenario and it can lead to discord between you and your patients. You may feel like saying, "Well fine then. I can't force you to help yourself..."You feel frustrated and the patient may not feel supported. Here are 30 reasons why your patient may be hesitant to take their pain medication and guidance on what you can do about it. Help your patients, improve your doctor-patient relationships, and reduce your frustration.Let me know how it goes!Delia Chiaramonte, MDwww.integrativepalliative.comFree guide for physicians to reclaim their wellbeing at work and in life: https://trainings.integrativepalliative.com/pl/2148540010 Coping Courageously: A Heart-Centered Guide for Navigating a Loved One's Illness Without Losing Yourself is available here: www.copingcourageously.com A free guide for physicians to help reclaim your joy at work and in life https://trainings.integrativepalliative.com/pl/2148540010Please review this podcast wherever you listen and forward your favorite episode to a friend! And be sure to subscribe!Sign up to stay connected and learn about upcoming programs:https://trainings.integrativepalliative.com/IPI-stay-in-touchI'm thrilled to be listed in Feedspot's top 15 palliative podcasts!https://blog.feedspot.com/palliative_care_podcasts/

Shivani Ruparel, Ph.D., Associate Professor and Director of Research in the Department of Endodontics at UT Health San Antonio, and her team are working on potential analgesics to help mitigate cancer pain.

This week the hosts look at research that shows medicinal cannabis can safely relieve cancer pain and curb total meds and opioid use, and they discuss how artificial intelligence may […]

This week the hosts look at research that shows medicinal cannabis can safely relieve cancer pain and curb total meds and opioid use, and they discuss how artificial intelligence may […]

Pain is a common side effect of breast cancer. The cancer itself may cause pain and nearly all breast cancer treatments may cause some type of pain. If breast cancer is metastatic – meaning it's spread to parts of the body away from the breast, such as the bones or liver – it may cause pain in those areas. There are many medicines that can ease cancer pain. Opioids are narcotic drugs that are commonly used to treat moderate to severe pain caused by breast cancer or its treatments. While effective, opioids can be habit-forming, which can be a problem for people with a history of addiction. Listen to the episodes to hear Dr. Moryl discuss: the difference between chronic and acute pain the difference between withdrawal symptoms and addiction pain control options for people with a history of substance abuse disorder

How does long COVID affect mental health? Find out about this and more in today's PV Roundup podcast.

Cochrane has produced more than a dozen systematic reviews of the effects of interventions that might help children who have chronic pain and their parents. In October 2023, these were added to with a review of qualitative research that had explored the experiences and views of children and their families about chronic non-cancer pain and pain services and treatments. In this podcast, Roses Parker, Cochrane's Commissioning Editor, talks with lead author Emma France, an associate professor in health research at the University of Stirling in the UK, about the review and its findings.

Cochrane has produced more than a dozen systematic reviews of the effects of interventions that might help children who have chronic pain and their parents. In October 2023, these were added to with a review of qualitative research that had explored the experiences and views of children and their families about chronic non-cancer pain and pain services and treatments. In this podcast, Roses Parker, Cochrane's Commissioning Editor, talks with lead author Emma France, an associate professor in health research at the University of Stirling in the UK, about the review and its findings.

Can a blood test identify patients at high risk for suicide? Find out about this and more in today's PV Roundup podcast.

Ryan kicks off the podcast with his trip to Mexico. Then Jesse talks about his mom, cancer and what the past few weeks has been like....  We then try to finish off on a lighter note with Jesse's new ass workout. We hope you find some value in this episode. Thanks you.

CME credits: 1.50 Valid until: 21-11-2024 Claim your CME credit at https://reachmd.com/programs/cme/kol-knockouttm-cancer-pain-management-edition/15994/ This enduring program of the live-virtual symposium will focus on the challenges of managing cancer pain using the Evolve KOL Knockout™ case-based format. The key opinion leaders (KOLs) will be challenged by the host/moderator to diagnose and manage patient scenarios with varying levels of difficulty. Learners will vote on the winner of each case presentation round and the moderator will declare a match winner at the conclusion. There will be learning, laughter, and only one KOL left standing! =

"How I Do It: Weaning Strategy for Intrathecal Drug Delivery Systems for Chronic Non-Cancer Pain: Sublingual Buprenorphine-Naloxone Microdosing Schedule" by Vanessa Choi Yin Wong, BSc, MD, Jill Osborn, MD, PhD, FRCPC, and Vishal Varshney, MD, FRCPC, FRCPC. From ASRA Pain Medicine News, August 2023. See original article at www.asra.com/august23news for figures and references. This material is copyrighted.   Support the show

 Why do I need two different medications for cancer pain? We explain their different roles and how using them as prescribed can improve your quality of life. In this Episode: 01:18 - Pumpkin Spice Muffins02:14 - Angel's Share and Devil's Cut05:26 - A Swan Song - History of the Phrase13:08 - Managing Breakthough Cancer Pain24:24 -  Ask the Ethicist: "I'm Dying of Cancer. Do I have to Tell Anyone?" Follow us on Facebook | Instagram | Email us at mail@every1dies.orgClick on this link to Rate and Review our podcast!

Effective management of a patient's pain is a key part of cancer care and various medicines have been suggested to help with this. These include cannabis-based medicines and medical cannabis, and in June 2023, we published a new Cochrane review of their effects. Here's one of the authors, Andrew Moore, a retired scientist formerly at the University of Oxford speaking from the depths of Devon in the UK, to tell us about the review's findings.

Effective management of a patient's pain is a key part of cancer care and various medicines have been suggested to help with this. These include cannabis-based medicines and medical cannabis, and in June 2023, we published a new Cochrane review of their effects. Here's one of the authors, Andrew Moore, a retired scientist formerly at the University of Oxford speaking from the depths of Devon in the UK, to tell us about the review's findings.

Not everyone with cancer may have cancer pain, but some do. If you have cancer that's spread or recurred, the chance of having pain is higher. Cancer pain takes many forms. It can be dull, achy, sharp or burning. It can be constant, intermittent, mild, moderate or severe. How much pain one feels depends on a number of factors, including the type of cancer one has, how advanced it is, where it's situated and one's pain tolerance. Pain can be caused by the cancer itself. Pain could happen if the cancer grows into or destroys nearby tissue. As a tumor grows, it can press on nerves, bones or organs. The tumor can also release chemicals that can cause pain. Listen to this interesting episode where we have demystified a few assumptions and clarified several aspects of cancer pain. Hope this helps. See you soon. Jai Hind

This week the hosts look at research that shows medicinal cannabis can safely relieve cancer pain and curb total meds and opioid use, and they discuss how artificial intelligence may change medicine. Plus, they share a healthy recipe for Cobb salad wraps.

This week the hosts look at research that shows medicinal cannabis can safely relieve cancer pain and curb total meds and opioid use, and they discuss how artificial intelligence may change medicine. Plus, they share a healthy recipe for Cobb salad wraps.

This podcast will review key concepts of pain management in patients with cancer, as well as key findings on drug interactions between various pain medications and immunotherapy. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Hosts Chris Joyce and Stephanie Winn sit down with Dr. David Copenhaver of the ⁠UC Davis Comprehensive Cancer Center⁠. Dr. Copenhaver is the Chief of the Division of Pain Management and is an anesthesiologist and pain medicine specialist with expertise in cancer pain management. To learn more about the UC Davis Comprehensive Cancer Center, visit ⁠https://health.ucdavis.edu/cancer⁠.

Experimental psychologist Dr Lauren Heathcote shares her expert knowledge about applying a BPS model to cancer pain and other chronic diseases. She talks about what this means for clinical practice, the new treatment opportunities, psychologically wise interventions and how to embed these strategies into existing medical models.   Dr. Lauren Heathcote is an Associate Professor of Health Psychology at King's College London. Her research focuses on understanding psychosocial influences on the experience of pain in young people, particularly youth with chronic illnesses such as cancer and chronic pain.   If you want to become really confident treating pain join us with Le Pub Premium Membership. Sign up at www.lepubscientifique.com  If you'd like to get in touch with Le Pub here's how: Email: lepubscientifique@gmail.com Twitter: @lepubscientifiq Instagram: @lepubscientifique LinkedIn: @LePubScientifique Join the Le Pub Community on Facebook: Le Pub Scientifique 

~Co-presented by The New School at Commonweal and CancerChoices~ Join Thomas Smith, MD, with Host Michael Lerner for a conversation about easing cancer pain and suffering. Uncontrolled pain creates unnecessary suffering, but when pain is controlled, quality of life improves dramatically. Compassionate, expert help is available for people with cancer experiencing pain. Thomas J Smith, MD Thomas is a professor of oncology at the Johns Hopkins University School of Medicine and director of Palliative Medicine for Johns Hopkins Medicine. He has a lifelong interest in better symptom management, communication, and improving access to high quality affordable care. Thomas is a fellow in the American College of Physicians, the American Society of Clinical Oncology, and the American Association of Hospice and Palliative Medicine and is listed among the top oncologists and palliative care specialists in the country. He has taught palliative concepts in more than a dozen countries and helped start over 100 new programs. Host Michael Lerner Michael is the president and co-founder of Commonweal. His principal work at Commonweal is with the Cancer Help Program, CancerChoices.org, the Omega Resilience Projects, the Collaborative on Health and the Environment, and The New School at Commonweal. He was the recipient of a MacArthur Prize Fellowship for contributions to public health in 1983 and is author of Choices in Healing: Integrating the Best of Conventional and Complementary Therapies (MIT Press). Find out more about The New School at Commonweal on our website: tns.commonweal.org. And like/follow our Soundcloud channel for more great podcasts.

“We as oncology nurses have to understand who is this patient, where do they come from, and who is going to touch that patient, so that we can provide comprehensive, good care without these barriers, or at least to eliminate as many of these barriers as much as we can,” ONS member Idalina Colburn, RN, OCN®, ONN-CG, nurse navigator at the Dana-Farber Cancer Institute in Boston, MA, told Jaime Weimer, MSN, RN, AGCNS-BC, AOCNS®, oncology clinical specialist at ONS, during a discussion about nursing care considerations for patients with developmental disabilities and cancer. You can earn free NCPD contact hours after listening to this episode and completing the evaluation linked below. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at myoutcomes.ons.org by March 3, 2025. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: The learner will report an increase in knowledge related to caring for patients with developmental disabilities and cancer. Episode Notes Complete this evaluation for free NCPD. Colburn's 44th Annual ONS Congress® ePoster: A Communication Tool to Assist With Coordination and Implementation of Cancer Care for Adults With Developmental Disabilities in Large Urban Medical Cancer Centers American Society of Clinical Oncology articles: Developmental Disabilities, COVID-19, and Cancer: Creating a Model of Flexible Comprehensive Care Autism and Cancer: Creating Comprehensive Solutions for Complex Needs Intellectual and Developmental Disabilities article: Are Researchers Addressing Cancer Treatment and Survivorship Among People With Intellectual and Developmental Disabilities in the U.S.? A Scoping Review Journal of Pain and Symptom Management article: Cancer Pain in People With Intellectual Disabilities: Systematic Review and Survey of Health Care Professionals Lancet Oncology article: Cancer Treatment Decision Making in Individuals With Intellectual Disabilities: A Scoping Literature Review American Nurses Association book: Intellectual and Developmental Disabilities Nursing: Scope and Standards of Practice (third edition) Oncodefi Highlights From Today's Episode “Barriers for these patients could be significant or mild. The barriers are directly related to the severity of the limitation of the individual. If you have a patient who presents with a cancer diagnosis for treatment and they have a developmental or intellectual disability, but they are pretty high functioning, the barriers that they present with may be very different than that patient who is really low functioning and severely impaired.” Timestamp (TS) 04:50 “We always have to consider how we assess and coordinate care for this patient population. It requires excellent coordination and communication with other providers who are caring for this patient. But mostly reaching out to the community, involving the family or the other caregivers. We as oncology nurses have to understand who is this patient, where do they come from, and who is going to touch that patient, so that we can provide comprehensive, good care without these barriers, or at least to eliminate as many of these barriers as much as we can.” TS 12:21 “The goal would be patient-centered, safe oncology care for every patient who hits your chair with a developmental disability. The idea behind it is that it uses a multidisciplinary approach to care. So, it utilizes the team, including your social workers, nursing assistance, navigators, really anyone who is going to touch that patient within the medical team, but also involves the family and those community caregivers, and government or state programs that take care of these patients as well. So, we utilize all of those pieces in assessment and coordination of a specific care plan for these patients.” TS 18:40 “We would want to identify the strengths for a patient, understand the level of comprehension and communication of that specific patient, what potential behaviors we might be needing to think about, what are the medical commodities that we need to address, and also an assessment of the level of training needed to the caregivers. So that when a patient leaves our chemo chair, those caregivers are prepared to provide the level of care that that patient needs in the community.” TS 19:34 “Patient-centered care would also include things like environmental barriers. Part of that plan would be thinking about what do we need to do with our environment to make it conducive. So, things like making sure that the patient has the same nurse as much as possible, making sure that they're not waiting in a waiting room and they're going right into a chair, that there's someone with them with their appointments whenever possible, that we allow extra time during those appointments. All of those things would be part of the care plan.” TS 20:21 “We as nurses are really in a prime position to advocate for this kind of level of care, to continue to educate ourselves. . . . I think that we can continue to make a difference, and I think community outreach is a great area that we need to do more of. And simply just educating ourselves and others and just talking about it.” TS 27:02

"A Comparison of Various Peripheral Nerve Stimulators Available Currently on the Market," by Vinita Singh, MD, MS, Director of Cancer Pain, Department of Anesthesiology, Emory University School of Medicine, Atlanta, Georgia. From ASRA Pain Medicine News, November 2022. See original article at www.asra.com/nov22news for figures and references. This material is copyrighted.  

Daniel C. McFarland, DO, and Dr. Kirk Harris, MD, both of the University of Rochester, spoke with CancerNetwork® about their manuscript titled, “Cancer Pain and Opioid Use Disorder,” which was recently published in the journal ONCOLOGY®. In the review, the authors explore current approaches for screening of opioid use disorder, evaluation of psychosocial stressors, factors that qualify the disorder, and management of patients suffering with addiction. Don't forget to subscribe to the “Oncology Peer Review On-The-Go” podcast on Apple Podcasts, Spotify, or anywhere podcasts are available. 

This episode features Dr Andrew Page (Academic Unit of Palliative Care, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK). Cancer pain is common, extremely debilitating, and undertreated worldwide. We do not know if non-steroidal anti-inflammatory drugs (aka NSAIDs or “anti-inflammatories”) are effective in managing cancer pain of any type. To further scientific understanding, UK palliative care doctors advocate a pragmatic trial to determine the role, if any, of NSAIDs as opioid adjuncts for treating cancer-induced bone pain. Numbers treated for cancer-induced bone pain at a single regional radiotherapy centre (478 per year) support the feasibility of trial recruitment. Considering eGFR and contraindicating co-morbidities, two-thirds could be suitable for NSAID prescription if proven efficacious. Suitability for NSAID prescription reduces with age, with the proportion unsuitable increasing in those over 65 years old. Recruitment to a future trial of NSAIDs in the management of cancer-induced bone pain appears feasible, particularly if multiple recruitment centres are used. Demonstrating feasibility allows the planning of a definitive clinical trial to determine the efficacy of NSAIDs in this patient group. Without a definitive clinical trial, the question remains: are effective analgesics being underutilised in cancer pain management, or are ineffective medications increasing the risk of side effects in an already co-morbid cancer population? Full paper available from:     https://journals.sagepub.com/doi/full/10.1177/02692163221122263 If you would like to record a podcast about your published (or accepted) Palliative Medicine paper, please contact Dr Amara Nwosu:  a.nwosu@lancaster.ac.uk

Link to bioRxiv paper: http://biorxiv.org/cgi/content/short/2022.09.06.506411v1?rss=1 Authors: Inyang, K. E., Evans, C. M., Heussner, M., Petroff, M., Reimers, M., Vermer, P. D., Tykocki, N., Folger, J. K., Laumet, G. Abstract: Severe pain is often experienced by patients with head and neck cancer and is associated with a poor prognosis. Despite its frequency and severity, current treatments fail to adequately control cancer-associated pain, because of our lack of mechanistic understanding. Cancer-derived small extracellular vesicles (Cancer-sEVs) are well-positioned to function as mediators of communication between cancer cells and neurons. Inhibition of Cancer-sEV release attenuated pain in tumor-bearing mice. Injection of purified Cancer-sEVs is sufficient to induce pain hypersensitivity in naive mice. Cancer-sEVs triggered calcium influx in nociceptors and inhibition or ablation of nociceptors protect against cancer pain. Interrogation of published sequencing data of human sensory neurons exposed to human Cancer-sEVs suggested a stimulation of protein translation in neurons. Induction of translation by Cancer-sEVs was validated in our mouse model and its inhibition alleviated cancer pain in mice. These findings define a role of Cancer-sEVs in cancer pain and identify several druggable targets. Copy rights belong to original authors. Visit the link for more info Podcast created by PaperPlayer

Title: Joint CNS-NANS Podcast: Procedural Management of Cancer Pain Faculty: Ashwin Viswanathan and William Rosenberg Moderator: Jeffrey Raskin

Pain is one of the most common, but complex symptoms for cancer patients. Both cancer and its treatments can cause pain and managing this pain is a personalized process. While there are numerous pharmacological and non-drug based approaches, improving pain can significantly impact quality of life. Oncology care teams and pain management specialists can help patients navigate options. Guest: Abhilasha Solanki, MD, pain management physician and anesthesiologist at Weill Cornell Medicine and NewYork-Presbyterian Hospital. Host: John Leonard, MD, a leading hematologist and medical oncologist at Weill Cornell Medicine and NewYork-Presbyterian Hospital.

India's national research agency is hoping to study cannabidiol (CBD) and its effects on cancer pain relief, the director of the agency has revealed in our latest NutraChampion podcast.

In this episode, The Good GP interviews GPs and medicinal cannabis prescribers, Dr Jamil Khan and Dr Lewis MacKinnon on prescribing cannabis and its use in chronic non-cancer pain. This episode covers the types of cannabinoids and what can be used in Australia, the evidence and indications for treating chronic non-cancer pain. We also explore the process for GPs to become a registered prescriber and the process involved in prescribing patients and managing their expectations. If you have a question or would like to get in touch with The Good GP, please email wa.events@racgp.org.au

AyurRekha- Cancer Pain

David Liew talks with clinical pharmacology registrar Gloria Wong about some of the challenges involved in the pharmacological management of chronic non-cancer pain in frail older people.

According to the National Cancer Institute, as many as half of patients with cancer have problems sleeping. Whether it's insomnia or abnormal sleep-wake cycles, consistent lack of sleep has a tremendous impact on both physical and mental health. That, along with the pain that often accompanies a cancer diagnosis, adds another layer of stress and discomfort to daily life. Relief is Possible Join Alyssa N. Van Denburg, a Clinical Health Psychologist at Northwestern Medicine as she shares strategies for managing pain and sleep. Dr. Van Denburg will discuss ways supportive care can improve your quality of life, including: How most cancer pain is manageable Why controlling pain is an essential part of treatment What sleep strategies work best during treatment, other illness, or the stress of caring for loved ones For more information on Rolfe and Wellness Wednesday visit: https://rolfefoundation.org/get-involved/events-programs/wellness-wednesday-3/

This program looks at how to treat cancer pain without opioids with Dr. Ann Shah. Series: "Mini Medical School for the Public" [Health and Medicine] [Show ID: 37518]

This program looks at how to treat cancer pain without opioids with Dr. Ann Shah. Series: "Mini Medical School for the Public" [Health and Medicine] [Show ID: 37518]

This program looks at how to treat cancer pain without opioids with Dr. Ann Shah. Series: "Mini Medical School for the Public" [Health and Medicine] [Show ID: 37518]

This program looks at how to treat cancer pain without opioids with Dr. Ann Shah. Series: "Mini Medical School for the Public" [Health and Medicine] [Show ID: 37518]

This program looks at how to treat cancer pain without opioids with Dr. Ann Shah. Series: "Mini Medical School for the Public" [Health and Medicine] [Show ID: 37518]

Kris Ferguson MD welcomes Dr. Hemant Kalia to the Get Healthy Podcast. Dr. Kalia specializes in interventional spine and cancer pain management with special expertise in advanced neuromodulation procedures. Listen in as two pain specialists discuss cancer treatment and where pain specialists fit into a comprehensive cancer treatment plan. What is the different between physical medicine rehab doctors and pain management doctors? What is pre-habilitation? How can traditional and alternative approaches to medicine be combined in cancer treatment? And why are controlled studies in pain management difficult and ethically challenging? Dr. Kalia earned his medical degree from Mahatma Gandhi Memorial Medical College in Indore; India and Master's degree in Public Health from Western Kentucky University in Bowling Green, KY. His first residency was in Preventive Medicine & Public Health followed by Physical Medicine & Rehabilitation at University of Rochester. He subsequently completed an ACGME approved Pain Medicine fellowship at University of Rochester and additional FIPP (Fellow of Interventional Pain Practice) certification from World Institute of Pain. Dr. Kalia is a member of numerous national/international professional societies and sits on various sub-committees. He is part of the Board of Directors at ASPN (American Society of Pain & Neuroscience) and Monroe County Medical Society. He is the Fellowship director of Interventional Spine & Pain fellowship program at Rochester Regional Health and is involved in teaching medical students, residents and fellows from other programs. He also is part of the faculty at national and international hands on cadaveric workshops for interventional spine and pain procedures. Dr. Kalia has presented his work on cancer pain and advanced neuromodulation at multiple national and international conferences including publications in peer-reviewed journals in the field of Pain Medicine. He is the current Editor-in-Chief of Advances in Clinical Medical Research & Health Care Delivery open access Journal.

Opioids play a critical role in managing cancer-associated pain, but they're highly addictive, and they don't always provide sufficient pain relief for cancer patients. Many patients therefore turn to cannabis or cannabis-derived products to help manage their pain, using them either as standalone treatments or as an adjuvant therapy to opioids. But does research support cannabis use for this purpose? The evidence is mixed, and some studies suggest there may indeed be benefits for cancer pain—but there's also reason for caution. How Much Research Is There? There's a relatively strong body of research on cannabis for the treatment of chronic pain generally, according to Eloise Theisen, RN, MSN, president of the American Cannabis Nurses Association and co-founder of Radicle Health, a cannabis education and advocacy organization. However, much of this research has focused on neuropathic pain in multiple sclerosis and spinal cord injuries, and comparatively few studies have examined pain in the cancer context. Among the studies that exist for cancer, many have small sample sizes, and study design is also an issue. “We have animal studies and some clinical human studies,” says Theisen, but there's “a lack of randomized controlled trials, which are considered to be the gold standard.” A further complicating factor in the research on cannabis and cancer pain is that most of the existing studies on this topic have relied on products that do not match those cancer patients actually use in practice. According to Hance Clarke, MD, PhD, associate professor of anesthesia at the University of Toronto and author of a recent review article on cannabis and pain,1 the products that have been studied most extensively are pharmaceutical-grade cannabis isolates, such as nabiximols (an extract containing THC and CBD in a precise one-to-one ratio), nabilone (synthetic THC), and dronabinol (also synthetic THC). However, cancer patients outside of the research context are much more likely to use dispensary cannabis and non-pharmaceutical-grade plant-based extracts. “We're kind of stuck without enough evidence on the products that people are currently using,” says Clarke. This is important, because patients may react quite differently to a dispensary product than to a pharmaceutical product, according to Clarke. Guests:  Eloise Theisen, MSN, RN, is a board certified Adult Geriatric Nurse Practitioner who specializes in cannabis therapy. For over 20 years, Eloise has worked primarily with cancer, dementia and chronic pain patients. In the last several years, Eloise has focused her efforts on cannabinoid therapies. Eloise was one of the first healthcare professionals to bring a clinical dosing regimen to the cannabis space. In 2019, Eloise was elected President of the American Cannabis Nurses Association and will serve through 2022. In 2019, Eloise co-authored Pain Free with CBD: Everything You Need to Know and Effectively Use Cannabidiol with Alice O'Leary Randall.    Joe Jeffries, Pharm D is currently Director of Pharmacy at FarmaceuticalRx, a medical cannabis dispensary in East Liverpool Ohio. Joe is the former Director of Pharmacy at Barnesville Hospital and was named the Healthcare Worker of the Year, largely for his creation of a program to help those struggling with drug addiction. Joe was also President of the Ohio Pharmacists Association from 2000-2001.  Host:  Joseph Friedman  CannaRPh Consultants CRx Magazine Advisory Board, CRx Podcast  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

19.  Dr. Lisa Stearns was a compassionate mentor to all of us pain management physicians, and a compassionate physician to her patients.  She treated mostly cancer patients, who depended on her for pain management for their difficult to treat pain. She passed away this weekend in a tragic accident at her home in Mexico.  She had placed "more intrathecal pumps than anybody else" had (per Dr. Grigsby).  I was, incredibly, one of the privileged many that was able to visit her clinic in Arizona and learn from her.  Her incredible devotion to the field and incessant dedication to her patients will be missed.  I sure will miss asking her about pumps and listening to her lectures.  I pray for her family, and her near and dear ones.  Thank you, again Dr. Stearns for what you have given the world.  Without you, the world will be a bit harder to live in.

This week, we discuss how cancer and cancer treatments cause pain. It also starts raining about 3/4 of the way through, so please excuse the background noise!

A panel responds to Roy's interview with Professor Jason Busse, who was speaking as an editor of the 2017 Canadian Guideline for Opioids for Chronic non-Cancer Pain. Guests: Barry Ulmer, executive director of the Chronic Pain Association of Canada Marvin Ross, health writer for HuffPost.com Dawn Rae Downton, freelance journalist and chronic pain patient Hilary Morden, entrepreneur, criminologist at Simon Fraser University and chronic pain patient (Photo: Rich Pedroncelli/The Canadian Press/AP) See omnystudio.com/listener for privacy information.

The Roy Green Show   Is Canada being too generous to illegal border crossers? And when should a historical figure's likeness be taken down?   Only 55% of Canadians would oppose removing Sir John A Macdonald's statues and only 53% of Canadians believe Canada is too generous to illegal border crossers.   Guest:  Shachi Kurl, executive director of Angus Reid polling   - A panel responds to Roy's interview with Professor Jason Busse, who was speaking as an editor of the 2017 Canadian Guideline for Opioids for Chronic non-Cancer Pain.   Guests: Barry Ulmer, executive director of the Chronic Pain Association of Canada Marvin Ross, health writer for HuffPost.com Dawn Rae Downton, freelance journalist and chronic pain patient Hilary Morden, entrepreneur, criminologist at Simon Fraser University and chronic pain patient - A viral post from Conservative Review addresses the thousands of ordinary men who saved countless lives in Houston. See omnystudio.com/listener for privacy information.